This inventor holds 1 USPTO granted patent. Top assignee: Abbott Laboratories Corporation. Active years: 2009.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2009
Title: Innovations of David C Park
Introduction
David C Park is a notable inventor based in Urbana, Illinois. He has made significant contributions to the field of pharmaceuticals, particularly in the development of compounds with antiangiogenic and anticancer properties. His work has the potential to impact cancer treatment and improve patient outcomes.
Latest Patents
David C Park holds a patent for "Sulfonamides having antiangiogenic and anticancer activity." This patent describes compounds that inhibit methionine aminopeptidase-2 (MetAP2). Additionally, it outlines pharmaceutical compositions that include these compounds, methods for treating cancer, and techniques for inhibiting angiogenesis.
Career Highlights
David C Park is associated with Abbott Laboratories Corporation, a leading global healthcare company. His work at Abbott has allowed him to focus on innovative solutions in the pharmaceutical industry. His research and development efforts contribute to advancing medical science and improving therapeutic options for patients.
Collaborations
David has collaborated with notable colleagues, including Kenneth M Comess and Scott A Erickson. These partnerships have fostered a collaborative environment that enhances the research and development process.
Conclusion
David C Park's contributions to the field of pharmaceuticals through his innovative patents and collaborations highlight his commitment to advancing cancer treatment. His work exemplifies the impact of dedicated inventors in the healthcare industry.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile